An international study of about 43,000 people has significantly expanded the number of genetic factors known to play a role in age-related macular degeneration (AMD), a leading cause of vision loss among people age 50 and older. Supported by the National Eye Institute (NEI), part of the National Institutes of Health, the findings may help improve our understanding of the biological processes that lead to AMD and identify new therapeutic targets for potential drug development.
Related posts:
- Avastin and Lucentis are equivalent in treating age-related macular degeneration At two years, Avastin (bevacizumab) and Lucentis (ranibizumab injection), two widely used drugs to treat age-related macular degeneration (AMD), improve vision when administered monthly or on an as needed basis, although greater improvements in vision were seen with monthly administration for this common, debilitating eye disease, according to researchers supported by the National Institutes of […]...
- Additional Genes Associated with Age-Related Macular Degeneration Identified Additional Genes Associated with Age-Related Macular Degeneration Identified...
- Medicare Card, Study reveals how genetic changes lead to familial Alzheimer’s disease Medicare Card, Study reveals how genetic changes lead to familial Alzheimer’s disease...
- Medicare Card, NIH researchers reveal link between powerful gene regulatory elements and autoimmune diseases Medicare Card, NIH researchers reveal link between powerful gene regulatory elements and autoimmune diseases...
- Medicare Card, Study reveals genomic similarities between breast cancer and ovarian cancers Medicare Card, Study reveals genomic similarities between breast cancer and ovarian cancers...
- USU study maps hotspots of genetic rearrangement Researchers have zoomed in on mouse chromosomes to map hotspots of genetic recombination — sites where DNA breaks and reforms to shuffle genes. The findings of the scientists at the National Institutes of Health and Uniformed Services University of Health Sciences (USU) have the potential to improve the detection of genes linked to disease and […]...
- Medicare Card Replacement, NIH BrIDGs program helps overcome research roadblocks Potential new treatments for a variety of cancers, spinal cord injury, and a rare disease that can lead to kidney failure are targets of a program that provides eligible scientists with no-cost access to National Institutes of Health therapeutic development contractor resources....
- Medicare, NHGRI charts course for the next phase of genomics research Medicare, NHGRI charts course for the next phase of genomics research...
- Medicare Card, NIH scientists uncover how immune cells sense who they are Medicare Card, NIH scientists uncover how immune cells sense who they are...
- Medicare Card, NIH study finds genetic link for rare intestinal cancer Heredity accounts for up to 35 percent of small intestinal carcinoid, a rare digestive cancer, according to findings from a team at the National Institutes of Health. The researchers examined families with a history of the disease. Because the disease has long been considered randomly occurring rather than inherited, people with a family history are […]...
- Medicare Card, Study identifies novel genomic changes in the most common type of lung cancer Medicare Card, Study identifies novel genomic changes in the most common type of lung cancer...
- Medicare Mouse study shows effect of blood pressure drug on Alzheimer’s disease A drug used decades ago to treat high blood pressure has been shown to improve learning and memory in mouse models of Alzheimer’s disease, according to a new study by researchers at the National Institute on Aging (NIA), part of the National Institutes of Health. The study found that the drug, diazoxide, acted on nerve […]...
- Medicare Card, Study breaks blood-brain barriers to understanding Alzheimer’s NIH-funded study suggests brain blood vessel cells may be therapeutic targets for Alzheimer’s disease. study in mice shows how a breakdown of the brain’s blood vessels may amplify or cause problems associated with Alzheimer’s disease. The results published in Nature Communications suggest that blood vessel cells called pericytes may provide novel targets for treatments and […]...
- HIV/AIDS Treatment Curbs Spread of HIV Among Drug Users, According to NIH Supported Study Highly active antiretroviral therapy (HAART), currently known for its therapeutic benefits against HIV, also reduced the spread of the virus among people with a history of injection drug use, according to a population-based study funded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health. The study was published […]...
- Medicare Card, New genetic link found between normal fetal growth and cancer Medicare Card, New genetic link found between normal fetal growth and cancer...